Form D — Sentonix, Inc.
0002039609-26-000003 · filed Aug 20, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $21,203,719
- Total sold
- $12,704,719
- Minimum investment
- $250,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Sentonix, Inc.
- CIK
- 2039609
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 1167 MASSACHUSETTS AVE
ARLINGTON, MA 02476 - Phone
- 617-388-6440
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Karl Schmidt · Executive OfficerArlington, MA Find on LinkedIn ↗
-
John Beaver · Executive OfficerArlington, MA Find on LinkedIn ↗
-
Kenan Turnacioglu · Executive OfficerArlington, MA Find on LinkedIn ↗
-
Jack Hoppin · DirectorArlington, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗